Tissue-predominant estrogen metabolic remodeling in adenomyosis revealed by LC-MS/MS profiling

Wang Q, Qing Wang, Liu B, BoYang Liu, Lei Kuang, Kuang L, Lingke Wang, Wang L, 仇颖莹, Chou Y, Yingying Chou, Bei Zhang, Zhang B, Wan G, Guiping Wan, Gui T, Tao Gui
The Journal of steroid biochemistry and molecular biology · 2026 · vol. 265 , pp. 107095 · doi:10.1016/j.jsbmb.2026.107095 · PMID:42532355 · W7171959188
Other OA: closed public-domain-us
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-01 ⓘ

LC-MS/MS profiling of adenomyosis tissue and serum revealed predominant increases in catechol estrogens within the tissue, linked to dysmenorrhea severity, rather than generalized serum estrogen elevation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Adenomyosis (AM) is an estrogen-dependent gynecological disorder in which local steroid handling may contribute to clinical heterogeneity. To characterize estrogen metabolic features in AM, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify 13 estrogens and estrogen metabolites in endometrial tissue and serum. Tissue metabolite profiles showed marked increases in catechol estrogens, particularly 2-hydroxyestrone (2-OHE1) and 4-hydroxyestrone (4-OHE1), whereas serum changes were more limited, with 2-methoxyestrone (2-MeOE1) representing the main circulating difference. Pathway- and ratio-based analyses indicated enhanced hydroxylation in tissue without a proportionate increase in downstream methylation-related readouts. Correlation and regression analyses further showed that tissue 2-OHE1 and 4-OHE1 were independently associated with dysmenorrhea severity. In exploratory receiver operating characteristic analyses performed within the discovery cohort, tissue catechol estrogens showed stronger discriminatory ability than serum metabolites. These findings suggested that AM was associated with endometrial tissue-predominant remodeling of estrogen metabolism rather than with generalized elevation of parent estrogens. The present study identified candidate metabolic markers requiring further validation and provided a framework for future investigation of local steroid metabolism in AM.

My notes (saved in your browser only)

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Endometrium Endometrium Endometrium Endometrium Endometrium Endometrium Endometrium

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (24)

SciLite annotations

chemicals 15
estrogen estrogen steroid estrogen estrone estrogen catechol estrone 2-hydroxyestrone 4-hydroxyestrone 2-methoxyestrone xenoestrogen estrogen estrone steroid

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-10-16T06:01:16.192504+00:00
pubmed
last seen: 2026-10-16T06:03:12.191140+00:00
scilite
last seen: 2026-08-09T09:47:33.675890+00:00
unpaywall
last seen: 2026-10-16T06:24:35.758740+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine